Georgia Clinical Trials
Browse actively recruiting clinical trials with research sites in Georgia. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in Georgia
- Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Limited-stage Small Cell Lung Cancer (LS-SCLC)Marietta, GA
- Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseaseNCT06847321PHASE2Lighthouse Pharmaceuticals, Inc.Alzheimer DiseaseColumbus, GA
- A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerNCT07100106PHASE1, PHASE2Genentech, Inc.Breast CancerAtlanta, GA
- A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell HistiocytosisNCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisAtlanta, GA
- A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)NCT07266402PHASE3Celldex TherapeuticsChronic Inducible UrticariaColumbus, GA
- ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerNCT07173751PHASE3BioNTech SEBreast Neoplasms
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)NCT06136650PHASE3Merck Sharp & Dohme LLCMetastatic Castration-resistant Prostate Cancer (mCRPC)Atlanta, GA
- A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)NCT07357727PHASE3Novartis PharmaceuticalsPrimary Myelofibrosis (PMF)Atlanta, GA
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's DiseaseNCT07011745PHASE3Bristol-Myers SquibbAlzheimer's DiseaseAtlanta, GA
- A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic MigraineNCT05711394PHASE3AbbVieEpisodic MigraineBrunswick, GA
- A Study to Evaluate the Effectiveness of DT-101 in Patients With DepressionNCT07300969PHASE2Draig Therapeutics LtdMajor Depressive Disorder (MDD)Atlanta, GA
- A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic DermatitisNCT07223697PHASE2Hoffmann-La RocheAtopic DermatitisAlpharetta, GA
Clinical trials by Georgia metro
Popular conditions in Georgia
Frequently asked questions
- How do I find clinical trials in Georgia?
- Corterve aggregates actively recruiting clinical trials with sites in Georgia from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in Georgia free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in Georgia?
- Georgia research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.